-
US troops in Syria killed in alleged IS ambush
-
Jalibert masterclass guides Bordeaux-Begles past Scarlets
-
M23 marches on in east DR Congo as US vows action against Rwanda
-
Raphinha double stretches Barca's Liga lead in Osasuna win
-
Terrific Terrier returns Leverkusen to fourth
-
Colts activate 44-year-old Rivers for NFL game at Seattle
-
US troops in Syria killed in IS ambush attack
-
Liverpool's Slot says 'no issue to resolve' with Salah after outburst
-
'Stop the slaughter': French farmers block roads over cow disease cull
-
Stormers see off La Rochelle, Sale stun Clermont in Champions Cup
-
Maresca hails Palmer as Chelsea return to winning ways against Everton
-
Hungarian protesters demand Orban quits over abuse cases
-
Belarus frees protest leader Kolesnikova, Nobel winner Bialiatski
-
Salah sets up goal on return to Liverpool action
-
Palmer strikes as Chelsea return to winning ways against Everton
-
Pogacar targets Tour de France Paris-Roubaix and Milan-San Remo in 2026
-
Salah back in action for Liverpool after outburst
-
Atletico recover Liga momentum with battling win over Valencia
-
Meillard leads 'perfect' Swiss sweep in Val d'Isere giant slalom
-
Salah on Liverpool bench for Brighton match
-
Meillard leads Swiss sweep in Val d'Isere giant slalom
-
Indonesia flood death toll passes 1,000 as authorities ramp up aid
-
Cambodia shuts Thailand border crossings over deadly fighting
-
First urban cable car unveiled outside Paris
-
Vonn second behind Aicher in World Cup downhill at St Moritz
-
Aicher pips Vonn to downhill win at St Moritz
-
Thailand says 4 soldiers killed in Cambodia conflict, denies Trump truce claim
-
Fans vandalise India stadium after Messi's abrupt exit
-
Women sommeliers are cracking male-dominated wine world open
-
Exhibition of Franco-Chinese print master Zao Wou-Ki opens in Hong Kong
-
Myanmar junta denies killing civilians in hospital strike
-
Why SpaceX IPO plan is generating so much buzz
-
Thailand continues Cambodia strikes despite Trump truce calls
-
US envoy to meet Zelensky, Europe leaders in Berlin this weekend
-
North Korea acknowledges its troops cleared mines for Russia
-
US unseals warrant for tanker seized off Venezuelan coast
-
Cambodia says Thailand still bombing hours after Trump truce call
-
Machado urges pressure so Maduro understands 'he has to go'
-
Leinster stutter before beating Leicester in Champions Cup
-
World stocks mostly slide, consolidating Fed-fuelled gains
-
Crypto firm Tether bids for Juventus, is quickly rebuffed
-
Union sink second-placed Leipzig to climb in Bundesliga
-
US Treasury lifts sanctions on Brazil Supreme Court justice
-
UK king shares 'good news' that cancer treatment will be reduced in 2026
-
Wembanyama expected to return for Spurs in NBA Cup clash with Thunder
-
Five takeaways from Luigi Mangione evidence hearings
-
UK's king shares 'good news' that cancer treatment will be reduced in 2026
-
Steelers' Watt undergoes surgery to repair collapsed lung
-
Iran detains Nobel-prize winner in 'brutal' arrest
-
NBA Cup goes from 'outside the box' idea to smash hit
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
J.AbuShaban--SF-PST